NCT03499431

Brief Summary

The purpose of this study is to evaluate the long-term safety and performance of complex endovascular aneurysm repair by inclusion in a longitudinal registry

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2018

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 9, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 17, 2018

Completed
13 days until next milestone

Study Start

First participant enrolled

April 30, 2018

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

April 17, 2018

Status Verified

April 1, 2018

Enrollment Period

2.8 years

First QC Date

April 9, 2018

Last Update Submit

April 9, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Longterm Aneurysm Related Mortality

    Death attributed to aneurysm rupture

    7 years

Interventions

Standard of care, treatment of thoracoabdominal aneurysms using endovascular techiniques.

Also known as: Branched and Fenestrated Devices

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients undergoing complex EVAR at study sites.

You may qualify if:

  • Patient eligibility for enrolment shall be based on known information at the time of the procedure. Information obtained at a later date may contradict these criteria, but this will not be considered a deviation of the Study Plan.
  • Patient requires endovascular repair of a thoracic, thoraco-abdominal or abdominal aortic or aorto-iliac aneurysm having morphology suitable for endovascular repair with complex endograft.
  • Patients (or their legal representative for minor patients) who do not object to (oral non-objection declaration, and signed consent form) collection and transmission of his/her data.

You may not qualify if:

  • Patients are excluded from enrolment into the study if any of the following are true:
  • Patients whose imaging follow-up is impossible, i.e. patients who are not able to send their follow up CT scans or Duplex US

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

AneurysmAortic Aneurysm

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesAortic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
7 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Co-Investigator

Study Record Dates

First Submitted

April 9, 2018

First Posted

April 17, 2018

Study Start

April 30, 2018

Primary Completion

March 1, 2021

Study Completion

March 1, 2023

Last Updated

April 17, 2018

Record last verified: 2018-04